av/g1-therapeutics--big.svg

COM:G1THERAPEUTICS

G1 Therapeutics, Inc.

  • Stock

Last Close

3.95

26/07 20:00

Market Cap

145.87M

Beta: -

Volume Today

492.24K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-6.68M
-
-20.26M
203.42%
-30.29M
49.49%
-60.12M
98.48%
-85.29M
41.86%
-122.45M
43.57%
-99.25M
18.94%
-148.35M
49.47%
-147.56M
0.53%
-47.97M
67.49%
depreciation and amortization
17.31K
-
42K
142.58%
67.23K
60.06%
89K
32.39%
175K
96.63%
356K
103.43%
582K
63.48%
469K
19.42%
530K
13.01%
513K
3.21%
deferred income tax
-278.85K
-
4.86M
1,842.89%
-1.37M
128.23%
-16.91M
-
-545K
96.78%
590K
208.26%
1.23M
-
stock based compensation
73.58K
-
389K
428.65%
1.39M
257.47%
3.39M
144.08%
10.22M
201.27%
16.45M
60.87%
18.77M
14.11%
22.32M
18.91%
20.59M
7.75%
14.51M
29.53%
change in working capital
205.26K
-
946K
360.87%
3.59M
279.65%
6.07M
69.07%
573K
90.56%
6.07M
959.51%
-4.08M
167.14%
-8.84M
116.83%
-5.31M
39.95%
-5.20M
1.96%
accounts receivables
205.26K
-
-237K
-
-5.45M
2,200%
-5.41M
0.83%
-1.59M
70.53%
inventory
-3.83M
-
-3.47M
9.42%
-12.71M
266.12%
3.74M
129.41%
accounts payables
6.33M
-
-1.00M
115.84%
248K
124.75%
-244K
198.39%
-675K
176.64%
4.42M
754.96%
-3.37M
176.27%
other working capital
946K
-
3.59M
279.65%
-253K
107.04%
1.57M
722.53%
5.82M
269.71%
237K
95.93%
759K
220.25%
8.39M
1,004.87%
-3.98M
147.40%
other non cash items
-115.84K
-
181K
256.25%
1.47M
713.69%
47K
96.81%
8K
82.98%
16.91M
211,312.50%
781K
95.38%
1.70M
118.18%
3.13M
83.51%
-1.42M
145.35%
net cash provided by operating activities
-6.50M
-
-13.85M
113.07%
-25.14M
81.59%
-50.52M
100.94%
-74.31M
47.09%
-99.57M
34.00%
-83.74M
15.90%
-132.11M
57.76%
-128.62M
2.64%
-38.34M
70.19%
investments in property plant and equipment
-103.09K
-
-87K
15.61%
-249.74K
187.06%
-294K
17.72%
-709K
141.16%
-2.72M
283.07%
-506K
-
acquisitions net
152K
-
50.02M
-
purchases of investments
-65.02M
-
-124.69M
91.76%
sales maturities of investments
15M
-
127.50M
750%
other investing activites
-50.02M
-
net cash used for investing activites
-103.09K
-
-87K
15.61%
-249.74K
187.06%
-294K
17.72%
-709K
141.16%
-2.72M
283.07%
152K
105.60%
-50.53M
-
2.81M
105.56%
debt repayment
-49.47K
-
-19.38M
-
-53.64M
176.78%
-26.69M
-
common stock issued
108.50M
-
339.59M
212.98%
2.71M
99.20%
2.31M
14.68%
86.43M
3,644.76%
52.38M
39.39%
-224K
100.43%
common stock repurchased
dividends paid
other financing activites
6.32M
-
33.18M
424.91%
49.76M
49.98%
-1.18M
102.38%
905K
176.50%
2.71M
198.90%
38.76M
1,332.90%
113.07M
191.73%
112K
99.90%
net cash used provided by financing activities
6.27M
-
33.18M
429.05%
49.76M
49.98%
107.32M
115.69%
340.49M
217.27%
2.71M
99.21%
21.69M
701.77%
145.86M
572.55%
52.49M
64.01%
-26.91M
151.27%
effect of forex changes on cash
4.02M
-
63K
-
net change in cash
3.69M
-
19.24M
420.95%
24.37M
26.62%
56.51M
131.90%
265.48M
369.81%
-99.58M
137.51%
-61.90M
37.84%
13.76M
122.22%
-126.65M
1,020.79%
-62.38M
50.75%
cash at beginning of period
3.69M
-
22.94M
520.95%
47.30M
106.23%
103.81M
119.45%
369.29M
255.73%
269.71M
26.97%
207.81M
22.95%
221.56M
6.62%
94.66M
57.28%
cash at end of period
3.69M
-
22.94M
520.95%
47.30M
106.23%
103.81M
119.45%
369.29M
255.73%
269.71M
26.97%
207.81M
22.95%
221.56M
6.62%
94.91M
57.16%
32.28M
65.99%
operating cash flow
-6.50M
-
-13.85M
113.07%
-25.14M
81.59%
-50.52M
100.94%
-74.31M
47.09%
-99.57M
34.00%
-83.74M
15.90%
-132.11M
57.76%
-128.62M
2.64%
-38.34M
70.19%
capital expenditure
-103.09K
-
-87K
15.61%
-249.74K
187.06%
-294K
17.72%
-709K
141.16%
-2.72M
283.07%
-506K
-
free cash flow
-6.60M
-
-13.93M
111.06%
-25.39M
82.25%
-50.81M
100.13%
-75.02M
47.63%
-102.29M
36.35%
-83.74M
18.13%
-132.11M
57.76%
-129.13M
2.26%
-38.34M
70.31%

All numbers in (except ratios and percentages)